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Abstract
Background:  The Immune Epitope Database and Analysis Resource (IEDB) is dedicated to
capturing, housing and analyzing complex immune epitope related data http://
www.immuneepitope.org.
Description: To identify and extract relevant data from the scientific literature in an efficient and
accurate manner, novel processes were developed for manual and semi-automated annotation.
Conclusion: Formalized curation strategies enable the processing of a large volume of context-
dependent data, which are now available to the scientific community in an accessible and
transparent format. The experiences described herein are applicable to other databases housing
complex biological data and requiring a high level of curation expertise.
Background
Many aspects of biological sciences have profited from the
recent advances in the field of bioinformatics. New com-
putational methodologies and tools allow researchers to
capture, store, analyze and model large volumes of data,
thereby dramatically affecting the pace, depth and scope
of scientific investigation. A prerequisite for computa-
tional analysis is the availability of experimental data in
an annotated, machine-accessible format. In research
areas such as genomics and proteomics, such databases
are a necessity, simply due to the vast amount of data gen-
erated. In the field of immunology, the majority of data
are only reported in the literature, due to the typically
smaller amounts of data distributed over many publica-
tions and to the dynamic and complex nature of immuno-
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logical interactions. Thus, accurate representation of these
data in a formalized fashion presents unique challenges.
Databases such as the International ImMunoGeneTics
information system (IMGT) [1], AntiJen [2], Functional
Immunology (FIMM) [3], HLA Ligand [4], SYFPEITHI [5]
and the HIV database [6] house immunologically relevant
information. They contain immunoglobulin-specific (Ig)
resources, T and B cell epitope sequence data, and/or
MHC binding data from peer-reviewed publications. Sim-
ilarly, the Protein Data Bank (PDB) [7] functions as a serv-
ice and repository for structural data and associated
metadata of immunological relevance. While these data-
bases are comprehensive in their respective scopes, they
do not capture detailed, functional and contextual infor-
mation related to immune epitopes in a structured man-
ner. One exception is the HIV database, which contains
detailed contextual descriptions of epitope recognition;
however, this information is captured as free text and
therefore, is not easily accessible for bioinformatics anal-
ysis.
To meet these challenges, the Immune Epitope Database
and Analysis Resource (IEDB) was established as a central-
ized repository of immune epitope-associated informa-
tion and related analysis tools [8,9]. It contains data on
epitope recognition by the antigen specific receptors of
the immune system, such as the structures bound by the T
cell receptor or antibody as well as epitope related data on
the interaction of an MHC with its peptide ligands.
Knowledge regarding epitope structure and the immune
response is important for the development of techniques
that detect, monitor, and prevent or treat diseases.
The scope of the IEDB incorporates critical features related
to the development of immune responses, such as data
relating to the host, the organisms targeted by the
immune response, and the biological context in which the
interactions take place. Epitopes recognized by humans as
well as all other host species are included, with current
priority given to those derived from the National Institute
of Allergy and Infectious Diseases (NIAID) Category A, B,
and C priority pathogens, emerging and re-emerging dis-
eases.
This is accomplished through modeling immune epitope
data in an original and highly customized database utiliz-
ing a specialized ontology, encompassing over 300 dis-
tinct data fields, and organized into various classes and
subclasses. These classes include epitope associated struc-
tural and source data, as well as contextual data such as
MHC binding, MHC ligand elution, and B and T cell
response data. Each class then contains a number of dis-
tinct fields, describing for example, the nature of the
immunogen or antigen involved, the immunization route
and schedule, and the assay type. A more detailed and
technical description of the IEDB's structural ontology has
been recently reported [10].
We here describe the design and implementation of a
curation process to manage large volumes of context-
dependent epitope-specific immunological data. The
complexity of these data precluded full automation of the
process and instead demanded sophisticated manual
curation and the participation of subject matter experts.
The necessity to capture a large volume of data in an accu-
rate and consistent manner, as well as to provide transpar-
ency to the scientific community, required the
development of a formalized approach to curation. Our
results have general implications for the curation of com-
plex, context dependent biological data, a prerequisite for
managing the ever expanding knowledge generated in
biological research.
Construction and content
Reference selection
The first step in our curation process is the selection of rel-
evant articles. This is accomplished through a search per-
formed on the entirety of the over 16 million citations in
PubMed using a complex and comprehensive query spe-
cifically constructed for this purpose. The query consists
of 61 keywords and logical operators to select epitope-
related references [see Additional file 1]. Keywords such as
"epitope", "major histocompatibility complex", "mimo-
tope", "antibody", and "HLA" are applied to select for
immune epitope related references in combination with a
keyword filter to limit the selection of references by pub-
lication date, language and publication type, excluding
review articles, editorials, meta-analyses, and comments.
The query was modified with the input of subject matter
experts who reviewed the results to ensure inclusion of all
relevant references. As of January 31st, 2006, the query
resulted in the selection of 96,565 references.
Figure 1a presents the number of potentially relevant ref-
erences identified by the year of publication. Few immune
epitope related references exist in PubMed before 1975. A
rapid increase in relevant articles was observed during the
late 1980s and then became steady at the current rate of
approximately 4,600 new references per year. Of the iden-
tified references, 6,954 references also contained key-
words associated with category A–C pathogens, a high
priority as established by the NIAID. Publications relevant
to epitopes from these pathogens began to appear in the
1970s with significant growth seen throughout the 1990s.
A further increase in the number of A–C related epitope
records is apparent from 2002 onwards, likely due to
heightened attention given to biodefense research (figure
1b).BMC Bioinformatics 2006, 7:341 http://www.biomedcentral.com/1471-2105/7/341
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Because the search criteria were designed to be highly
inclusive, some of the retrieved references are not actually
relevant to the scope of the database and further manual
review is required. After selection by the automated query,
abstracts are formally reviewed for their relevance to the
IEDB scope. Of the query selected references relating to
the category A–C pathogens, 1,947 (28%) were deemed
relevant to the scope of the project. Applying this same
ratio to the broad set of 96,565 epitope-based articles, we
estimate that a total of 27,000 articles currently exist in
PubMed with potentially curatable epitope-related data.
As described above, the selection process for curatable ref-
erences utilizes a combination of computer-based query
and active evaluation by subject matter experts. We now
have expert classifications for more than 11,000 abstracts
into 'curatable' and 'uncuratable', generating a substantial
dataset. Utilizing this dataset as a model, the process of
manual abstract scanning and categorization can likely be
automated using text classification tools tools. In a prom-
ising preliminary study of Latent Semantic Indexing,
Naive Bayes Classifiers and Support Vector Machines clas-
sification techniques demonstrated that an automated
approach could be applied to identify relevant abstracts.
The curation and review teams
Capturing the complex context-dependent features of
immune epitopes required the design and implementa-
tion of a novel approach to the data curation process. Few
descriptions of manual data curation procedures have
been reported in the literature [11,12]. In some cases, a
flexible workforce of part time undergraduate staff has
been utilized, but this strategy is inadequate when the
data require considerable subject matter expertise. Large-
scale involvement of experts can overcome this problem,
as exemplified by the FANTOM project [13] and the initial
phases of annotation of the human genome [14]. How-
ever, the ability to induce interest and commitment from
large numbers of field experts is dependent upon the pos-
sibility of generating high impact publications in a rela-
tively short time frame and is not sustainable in the long
term.
Previous immunological databases have relied on close
interactions between the immunological experts leading
the database development and a limited number of dedi-
cated curators, without the need for formalized processes
to be developed. This approach has the advantage of pro-
ducing high quality curation, but is not suited to large-
scale curation of substantial amounts of data.
The complexity and volume of data within the scope of
the IEDB project requires that manual curation be per-
formed by a team of dedicated curators (the Curation
Team; CT) with expertise in the areas of biochemistry,
microbiology and immunology. Immunological expertise
and independent assessment of the CT activities are pro-
vided by the Epitope Council (EC), an independent group
of senior immunologists and structural biologists. In
weekly meetings involving all CT and EC members, novel
issues arising in the curation and review of specific refer-
ences are discussed, together with curation rules, and
work process issues. These meetings serve to educate new
members through direct illustration of curation rules as
applied to the references discussed. In this manner, a
novel structure that efficiently integrates immunological
experts and data curators allows the optimization of com-
munication, curation consistency and continued training
of the personnel involved in the project.
Curation and review process
Electronic versions of the potentially relevant manuscripts
are selected from a queue housed on an internal website
Epitope related references present in PubMed Figure 1
Epitope related references present in PubMed. a. Ref-
erences related to epitopes derived from all sources. b. Ref-
erences related to epitopes derived from NIAID Category 
A–C pathogens.
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and further analyzed by the CT. Because the initial evalu-
ation of each manuscript is based solely on information
contained within the abstract, the first step in the analysis
is to assess whether the reference meets objective inclu-
sion criteria. For example, our guidelines exclude refer-
ences that do not include experimental immunological
data, only relate to molecular structures larger than 50
amino acids in length or 5,000 Dalton in mass, use
epitopes merely as tags for detection or purification exper-
iments, or only report theoretical data without experi-
mental validation. To date, approximately 35% of all
references selected by query and initially approved
through abstract review have been subsequently catego-
rized as uncuratable (figure 2).
Once the manual curation of a reference is complete, the
manuscript, the curation report, and tracking information
are sent to the EC for review. This process is designed to be
highly interactive and often requires the alteration of
existing curation or "recuration" of the data prior to
approval. Once approved by the EC, the curation item is
promoted to the IEDB production site where it is then
available for the scientific community. All internal site
transactions and comments regarding the curation are
retained for tracking, future referral, and educational pur-
poses.
Curation guidelines
The main challenge in the curation process is the accurate
translation of the information contained in the literature
into the structured format of the database. Epitope-spe-
cific interactions and assays are categorized by their
immunological context, which refers to MHC binding and
natural MHC presentation, as well as T cell and antibody
interactions. For each interaction or assay, the context is
specified by fields describing concepts such as the experi-
mental MHC molecule, antibody type, immunogen,
immunization procedure, carriers or adjuvants utilized
and the type of assay performed with the qualitative and/
or quantitative results. To illustrate the complexity of the
relationships found in epitope-related data, figure 3
depicts example fields present in contexts such as epitope
structure, immunization, and B cell response. The formal
ontology of the IEDB provides the platform upon which
the curation is based. A more detailed report of this ontol-
ogy was recently published [10].
The nature of the data encountered in the literature led us
to develop a Curation Manual and Data Dictionary to
ensure the validity and standardization of the curation
process. In these documents, rules, definitions, and guide-
lines were established to provide instructions regarding
the strategies and procedures for capturing, annotating
and introducing data from the literature into the IEDB.
Although curation manuals of similar content are availa-
ble for other immunological and biological databases
[12,15-18], the specific relationships and complex nature
of immune epitope data required novel guidelines of an
explicit nature. For flexibility and accuracy, these guide-
lines are continually updated as new scenarios are
encountered in the literature. Consensus is sought from
the CT, EC and external subject matter experts prior to
implementation. In this way, complex experimental data
are captured in a consistent and accurate manner. The
Curation Manual and Data Dictionary may be viewed on
the IEDB website. In addition to serving as an internal tool
for training and curation, the public availability of the
Curation Manual may facilitate external submissions to
the database, as well as ensure the transparency of the
The IEDB curation process and statistics Figure 2
The IEDB curation process and statistics.BMC Bioinformatics 2006, 7:341 http://www.biomedcentral.com/1471-2105/7/341
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curation process and the criteria utilized by the IEDB staff
to the scientific community at large.
The definitions established within the Data Dictionary are
incorporated throughout the database. The system will
display the definition and relevant information from the
Curation Manual for a given field in the form of hints and
on-line help.
Computer assisted curation
As described above, the Curation Manual and the ontol-
ogy of the database provide guidelines for the identifica-
tion and manual curation of relevant epitope data. In
order to enforce these guidelines and maximize curation
accuracy as well as efficiency, the database contains a
number of curation tools. One such application is the use
of 'finders', which are widely utilized throughout the
IEDB. Finders translate curator input into an established
and controlled vocabulary as maintained in external data-
bases focused on related and partially overlapping knowl-
edge domains. For example, the source species and strain
from which an epitope was derived are entered through
the use of the Species Finder application, reflecting the
established National Center for Biotechnology Informa-
tion (NCBI) taxonomy. Through the use of synonyms,
diverse terms present in the literature are mapped into a
controlled vocabulary. Thus, the use of a shared vocabu-
lary increases curation speed and data consistency, and
connects the information contained in multiple data-
bases. A similar effect is achieved for fields with a limited
number of valid values through the use of drop down
menus. The values present in these menus are subject to
review by subject matter experts and are capable of evolu-
tion in parallel with the literature.
Curation is also assisted through inter-field validation,
performed through automatic filling of linked fields.
Essentially, certain fields dictate higher order concepts,
Relationships between an epitope and contexts Figure 3
Relationships between an epitope and contexts.BMC Bioinformatics 2006, 7:341 http://www.biomedcentral.com/1471-2105/7/341
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allowing the system to fill select subfields. For example,
the field values describing the type of assay antigen will be
automatically filled by selecting Epitope Source Species as
the assay antigen. In this case, the information previously
entered manually describing the source species of the
epitope will be entered into the fields describing the assay
antigen. Additionally, copy capabilities simplify curation
and minimize curator error. Entire epitope records,
including experimental contexts, can be copied. Such cop-
ies may then be altered to correspond to a different
epitope, allowing for efficient curation of data from refer-
ences with multiple epitopes.
Outcome curation
In order to simplify the curation process and accommo-
date large volumes of similar data within a given refer-
ence, the concept of outcome curation was developed.
Outcome curation applies to the use of one immunologi-
cal context to capture a number of similar experimental
assays presenting the same outcome. For example, data
describing the use of varying immunogen dose and result-
ing in the same qualitative outcome may be captured as
one context entry. In order to minimize the potential for
loss of detailed data, this strategy is governed by strict
guidelines. This concept is only applied to multiple assays
in which the variable is of limited consequence, such as
dose or incubation duration, and not to multiple assays
with critical differences such as the MHC allele or host
species. Thus, the significance of all of the data is captured
in an efficient manner. Outcome curation provides an
effective strategy for enhancing the IEDB from both the
curator's perspective, as well as the end user's perspective.
It enables curators to capture a large amount of relevant
data in a single representative entry in order to accelerate
the curation process while preserving the richness of con-
text-dependent information in an objective fashion. Fur-
thermore, outcome curation offers benefits to the end user
in the form of concise, non-redundant data.
The curation tracking system
The curation of a large number of references by a team of
curators and reviewers required the development of a for-
mal tracking system. This specialized system allows for-
mal tracking of the progress of curation from selection of
the manuscripts until approved promotion into the IEDB,
or finalization as uncuratable. The assignment of the ref-
erence to a member of the CT, the initial completion of
curation, the assignment of the curation to an EC member
for review, and the final approval of each curation are
tracked. In this way, the progress of curation is monitored
in real-time. Due to the large number of references rele-
vant to the scope of this project, the tracking system has
proven to be an invaluable tool in the management and
development of the database, facilitating performance
evaluation and identification of impediments to allow
efficient reallocation of resources. Furthermore, the track-
ing system allows close monitoring of progress towards
set goals and quick and effective direction of curation
efforts towards high priority targets, as recently demon-
strated by the complete curation of all references relating
to Influenza A epitopes (Bui et al, manuscript in prepara-
tion) in a relatively short period of time.
The processes and strategies described in the present
report were developed over the course of the last year. Fig-
ure 4 depicts the output of finalized, manually curated ref-
erences, including the entry of all distinct molecular
structures and relevant experimental contexts over a
period of 34 weeks starting June 13th, 2005. In all, over
1200 references were manually curated, with the rate of
papers/week increasing in the latter part of the year, reflec-
tive of process optimization and the experiences gained by
the CT and EC groups. Curation output slowed during
weeks 26–30 due to transition from an internal system
into a web-based curation site, performed over the holi-
day season. In accordance with the prioritization of the A–
C pathogens, the curation of about 60% of the references
pertaining to these pathogens has been completed.
The number of molecular structures captured is 12,201
with the number of distinct epitopes, defined as molecu-
lar structures associated with positive data for at least one
context, at 8,144 as of March 2006. These results give an
average of 12 structures per curatable reference examined,
Total references processed as of February 5th 2006 Figure 4
Total references processed as of February 5th 2006.
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thus indicating that references frequently contain data
related to more than one epitope or molecular structure
and the same epitope may be reported by more than one
curated reference. The corresponding total number of
individual epitope contexts or assays curated is 27,431 or
3.4/epitope. These figures underscore how the IEDB cura-
tion strategy allows for the manual extraction of contex-
tual information from immunological literature in an
efficient manner.
Utility and discussion
A novel process designed to capture complex and context-
rich epitope data derived from relevant scientific literature
has been presented. This process is multi-step, involving
an automated query, a manual abstract scan to select
potentially relevant references, followed by methodical
analysis of the selected references, and finally the manual
curation of papers deemed relevant to the scope of the
database. This process controls quality, consistency and
uniformity through an interactive review of the curated
data by immunological experts and the development of a
formalized set of curation rules. The selection of relevant
references and tracking of the curation progress for a large
number of references has been documented. Finally, tools
to aid the curation process, such as finders, inter-field val-
idation features and copy capabilities have been
described.
Based upon the development of an optimized curation
procedure, we have been able to process and finalize over
a thousand references within a six-month period, with a
trend towards further increase in curation speed. At our
present pace, capturing all references containing immune-
epitope related data will be completed within the next 5
to 10 years, depending upon the use of automated strate-
gies and the size of the curation team.
The quality of the data captured by the IEDB has been fur-
ther strengthened through continued recuration efforts.
As new experimental scenarios are encountered in the lit-
erature, the rules applied to curation are expanded. On an
on going basis, feedback from external experts in the fields
of immunology and infectious diseases is sought in order
to improve both the database structure and the curation
practices. The curation tools and all fields and values uti-
lized by the database are undergoing continual reevalua-
tion and expansion. Improvements in all areas are
retroactively applied to previously curated data in order to
increase the sophistication of all data present within the
IEDB. That it is impossible to anticipate all variations of
data that can occur before the implementation of curation
strategies represents an important lesson and illustrates
the need for flexible design in curation systems handling
such complex data.
The high quality achieved through manual curation com-
promises the speed at which data can be added to the
database. The growing field of text mining may offer great
utility to our reference selection process and to curation
itself. The concept of automated field population is being
embraced by the bioinformatics community with the
development of numerous text mining programs such as
Textpresso [19] and PreBIND [20], automated text recog-
nition [21,22] and semi-automated annotation
approaches [23,24]. These programs have the potential to
increase the speed and accuracy of curation through auto-
matic selection of relevant data and completion of data-
base fields. However, these approaches are best suited to
largely context independent data, and therefore not read-
ily applicable to complex immunological relationships
requiring interpretation of intricate experimental con-
texts. In the future, the large set of curated data generated
by the IEDB could be utilized as a training tool for an
appropriate text mining tool to attempt automation of the
curation process itself.
Conclusion
Increasingly, the process of scientific discovery depends
upon the efficient retrieval of primary and secondary
information from large databases storing highly sophisti-
cated and annotated data. The processes involved in the
creation of such complex databases determine their suc-
cess as research tools. While some of the procedures
described herein are undoubtedly utilized by other scien-
tific databases, this information is difficult to access as
details of the procedures used for in-depth literature-
based curation are not generally available. Although our
observations may be somewhat specific to our database,
the lessons learned and the processes established during
the implementation of the IEDB can be applied to the
curation of experimental data relevant to other research
areas presenting similar challenges. Thus, we hope that
our experiences might be of some use to the developers
and users of projects capturing complex and context-
dependent non-immunological data as well.
Availability and requirements
Consistent with our goal to optimize the manual and
automated curation of complex data, encourage transpar-
ency of the associated processes, and facilitate integration
between distinct databases, the IEDB project, together
with the relevant code and documentation, are freely
available to the scientific community http://
www.immuneepitope.org/downloadDocuments.do.
The National Institute of Allergy and Infectious Diseases
(NIAID) Category A, B, and C priority pathogens, emerg-
ing and re-emerging diseases list is available at: http://
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